Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 501 of 6351
-
Freezing out thyroid tumors: a new weapon in the fight?
Disease control Recruiting nowThe goal of this clinical study is to learn if cryoablation works to treat thyroid tumors. It will also learn about the safety of cryoablation for thyroid tumors. The main questions it aims to answer are: * Does cryoablation shrink thyroid tumors over time? * What side effects o…
Sponsor: Yukun Luo • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for melanoma patients who Don't respond to standard immunotherapy
Disease control Recruiting nowThis clinical trial is for patients with stage 3 cutaneous melanoma and patients with mucosal melanoma who are able to have surgery to remove all tumour deposits. To improve the chance that melanoma will not recurr, new experimental combinations of a type of treatment called immu…
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New injection could help sleep apnea without CPAP
Disease control Recruiting nowThe aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP
Phase 3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Gout drug pegloticase gets a shot in the arm: new subcutaneous option tested
Disease control Recruiting nowThe primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus pegloticase 8 mg intravenously (IV) every two weeks with MTX on the response rate during Month 6, as measured by the sustained nor…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Botox in the womb: a new hope for crippling period pain?
Symptom relief Recruiting nowThe objective of the study is to evaluate the global impression of improvement at 3 months following intramyometrial botulinum toxin injections via hysteroscopy in women with severe primary dysmenorrhea who have failed first-line medical treatment, compared to intramyometrial pla…
Phase 3 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat throat cancer
Disease control Recruiting nowThis is a single-center, prospective, single-arm, phase II clinical study, to evaluate the therapeutic efficacy and safety of envafolimab combined with chemoradiotherapy and recombinant human endostatin in patients with locally advanced nasopharyngeal carcinoma.
Phase 2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pneumonia vaccine VAX-31 aims to boost protection in older adults
Vaccine OngoingThe study will evaluate the safety, tolerability, and immunogenicity of VAX-31 in adults ≥50 years of age.
Phase 3 • Sponsor: Vaxcyte, Inc. • Aim: Vaccine
Last updated Jul 02, 2026 00:00 UTC
-
Virtual reality headsets may calm cancer patients before radiation
Symptom relief By invitation onlyIntroduction: External Beam Radiotherapy is a common strategy used in the treatment of various cancers, and the patient undergoing treatment using this strategy many times experiences anxiety and stress. While patient education is essential for anxiety management, traditional met…
Sponsor: Oman Ministry of Health • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a 5-Minute chat with the school nurse ease childhood anxiety?
Symptom relief Recruiting nowAll enrolled students and their parents or guardians will complete baseline anxiety questionnaires. Students with a positive baseline screen will receive a brief school nurse-delivered coping skill, referral support when indicated, and follow-up assessments at approximately three…
Sponsor: McLaughlin Research Institute for Biomedical Sciences, Inc. • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New hope for lupus patients: drug trial targets kidney damage
Disease control Recruiting nowThe goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic lupus erythematosus and active lupus nephritis. It will also learn about the safety of cenerimod. The main questions it aims to ans…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Smart insulin pump takes on diabetes and stomach paralysis
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Sponsor: Viral N. Shah • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New Dual-Target CAR t therapy aims to control multiple myeloma early
Disease control Recruiting nowThis is a phase 1b study evaluating if BMS-986453 is safe and effective in treating people who have newly diagnosed multiple myeloma after completing initial therapy (induction) when a stem cell transplant is not intended.
Phase 1 • Sponsor: Susan Bal • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Brain Scan-Guided procedure could boost stroke recovery
Disease control Recruiting nowThe investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to evaluate the efficacy and safety of perfusion-guided endovascular treatment (EVT) compared to standard medical care for patients with acute ischemic stroke…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for hard-to-treat myeloma: experimental drug enters phase 2 trial
Disease control Recruiting nowThe purpose of this study is to evaluate how well JNJ-79635322 works (efficacy) in participants with Relapsed or Refractory Multiple Myeloma (RRMM; a cancer that forms in a type of white blood cells called a plasma cell. Cancer is called relapsed if it comes back after treatment …
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Promising cocktail targets brain cancer
Disease control Recruiting nowThis is a multicenter, open-label, single-arm, prospective clinical study of PD-1 inhibitor combined with rituximab, methotrexate, and orelabrutinib (PD-1i+RMO) in the treatment of newly diagnosed primary central nervous system lymphoma (ND-PCNSL) and secondary central nervous sy…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Weekly shot shows promise in major obesity trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes. The study has two phases: a main phase and an extension phase. Participation in the main phase of the study will last about 75 w…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a gentle ear zap calm the Brain's overactive 'Fight or Flight' response?
Disease control Recruiting nowThe significance of developing a safe and effective therapy for aneurysmal subarachnoid hemorrhage (aSAH) patients suffering cerebral vasospasm (CVS) cannot be overstated. Vasospasm - a clamping down of normal arteries in the days following rupture - remains incredibly challengin…
Sponsor: Marshall Holland • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for tough colorectal cancer: JSKN003 trial launches
Disease control Not yet recruitingThe study is being conducted to evaluate the efficacy and safety of JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan subjects.
Phase 3 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for rare cancer: tarlatamab takes on chemo in phase 3 trial
Disease control Recruiting nowBased on the efficacy of tarlatamab in patients with small-cell lung cancer, we aim to assess the efficacy of tarlatamab in patients with Advanced, pulmonary (large-cell only) or gastroenteropancreatic neuroendocrine carcinoma.
Phase 3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug cocktail targets tough lung cancers
Disease control Recruiting nowThe study is to explore the the reasonable dosage and to evaluate the efficacy, safety and tolerability of HLX43 (Anti-PD-L1 ADC) in combination with Serplulimab (anti-PD-1 humanized monoclonal antibody injection) in patients with advanced lung cancer.
Phase 2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC